We continue to hear from Stryker hip recall patients who have suffered serious complications, allegedly due to failing Rejuvenate and ABG II hip stems. It’s not surprising that the number of filings in this litigation have doubled in such a short time.
New York, New York (PRWEB) May 31, 2013
Stryker hip lawsuit claims filed in the wake of the July 2012 recall for Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount in courts throughout the country, Bernstein Liebhard LLP reports. According to a Case List posted on the Court’s website on May 28th, 161 Stryker hip recall lawsuits have been filed in a consolidated litigation now underway in New Jersey’s Bergen County Superior Court. Court records indicate that 81 claims had been filed in the New Jersey litigation when it was first established earlier this year. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“We continue to hear from Stryker hip recall patients who have suffered serious complications, allegedly due to failing Rejuvenate and ABG II hip stems. It’s not at all surprising that the number of filings in this litigation have doubled in such a short time,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including clients who have filed Stryker hip lawsuits. The Firm is currently offering free legal evaluations to alleged victims of Stryker Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Stryker’s Rejuvenate and ABG II hip stems were recalled in July 2012, after the metal hip replacement components were found to be prone to fretting and corrosion at the modular neck junction. Should this occur, Stryker says recipients may suffer pain and adverse local tissue reactions, as well as the need to have the hip replaced. The latest Stryker hip recall update advised affected patients to undergo metal ion blood testing and cross sectional imaging to determine if their hips are functioning properly, even if they have not experienced any signs or symptoms that would indicate their hip implants are failing.*
According to filings in the New Jersey litigation, Stryker hip lawsuit plaintiffs have allegedly suffered numerous complications due to the recalled components, including local tissue reactions manifesting with pain and/or swelling, and other adverse outcomes including metallosis, necrosis and osteolysis. Judge Brian R. Martinotti, who is overseeing the New Jersey Stryker hip recall litigation, has scheduled a Case Management Conference for June 18th.
Earlier this year, a number of plaintiffs in federally-filed Stryker hip replacement lawsuits petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to establish a consolidated proceeding for those claims in a single federal court. The Panel heard Oral Arguments on the matter yesterday, and is expected to render a decision soon. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))
Individuals allegedly affected by the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, and pain and suffering. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case evaluation, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP